These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12504656)

  • 1. Angiogenesis and invasive recurrence in ductal carcinoma in situ of the breast.
    Teo NB; Shoker BS; Jarvis C; Martin L; Sloane JP; Holcombe C
    Eur J Cancer; 2003 Jan; 39(1):38-44. PubMed ID: 12504656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular density and phenotype around ductal carcinoma in situ (DCIS) of the breast.
    Teo NB; Shoker BS; Jarvis C; Martin L; Sloane JP; Holcombe C
    Br J Cancer; 2002 Mar; 86(6):905-11. PubMed ID: 11953822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymidine phosphorylase expression and stromal vascularity in ductal carcinoma in situ of the breast.
    Teo NB; Shoker BS; Jarvis C; Sloane JP; Holcombe C
    J Clin Pathol; 2003 Dec; 56(12):919-23. PubMed ID: 14645350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombospondin 1 protein expression relates to good prognostic indices in ductal carcinoma in situ of the breast.
    Rice AJ; Steward MA; Quinn CM
    J Clin Pathol; 2002 Dec; 55(12):921-5. PubMed ID: 12461058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenic potential of ductal carcinoma in situ (DCIS) of human breast.
    Vogl G; Dietze O; Hauser-Kronberger C
    Histopathology; 2005 Dec; 47(6):617-24. PubMed ID: 16324200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of different immunohistochemical methods in the assessment of angiogenesis: lack of prognostic value in a group of 77 selected node-negative breast carcinomas.
    Siitonen SM; Haapasalo HK; Rantala IS; Helin HJ; Isola JJ
    Mod Pathol; 1995 Sep; 8(7):745-52. PubMed ID: 8539232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphometric and immunohistochemical study of angiogenic marker expressions in invasive ductal carcinoma of human breast.
    Safwat MD; Habib F; Elayat A; Oweiss N; Reffat S; Algaidi S
    Folia Morphol (Warsz); 2009 Aug; 68(3):144-55. PubMed ID: 19722158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic contrast-enhanced MRI reveals the extent and the microvascular pattern of breast ductal carcinoma in situ.
    Santamaría G; Velasco M; Farrús B; Caparrós FX; Fernández PL
    Breast J; 2013; 19(4):402-10. PubMed ID: 23758454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The assessment of angiogenesis and fibroblastic stromagenesis in hyperplastic and pre-invasive breast lesions.
    Pavlakis K; Messini I; Vrekoussis T; Yiannou P; Keramopoullos D; Louvrou N; Liakakos T; Stathopoulos EN
    BMC Cancer; 2008 Apr; 8():88. PubMed ID: 18384688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does thymidine phosphorylase correlate with angiogenesis in intraductal carcinoma of the breast?
    Erkus M; Meteoglu I; Culhaci N; Meydan N; Erdogdu I
    Saudi Med J; 2006 Sep; 27(9):1329-33. PubMed ID: 16951768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microvessel density and distribution in ductal carcinoma in situ of the breast.
    Guidi AJ; Fischer L; Harris JR; Schnitt SJ
    J Natl Cancer Inst; 1994 Apr; 86(8):614-9. PubMed ID: 7511693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic analysis of ductal carcinoma in situ of the breast using dynamic MR mammography.
    Oshida K; Nagashima T; Ueda T; Yagata H; Tanabe N; Nakano S; Nikaidou T; Funatsu H; Hashimoto H; Miyazaki M
    Eur Radiol; 2005 Jul; 15(7):1353-60. PubMed ID: 15789211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis in the progression of breast ductal proliferations.
    Carpenter PM; Chen WP; Mendez A; McLaren CE; Su MY
    Int J Surg Pathol; 2011 Jun; 19(3):335-41. PubMed ID: 19403546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stromal architecture and periductal decorin are potential prognostic markers for ipsilateral locoregional recurrence in ductal carcinoma in situ of the breast.
    Van Bockstal M; Lambein K; Gevaert O; De Wever O; Praet M; Cocquyt V; Van den Broecke R; Braems G; Denys H; Libbrecht L
    Histopathology; 2013 Oct; 63(4):520-33. PubMed ID: 23889174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of myofibroblast cells and microvessels around invasive ductal carcinoma of the breast and comparing with the adjacent range of their normal-to-DCIS zones.
    Dabiri S; Talebi A; Shahryari J; Meymandi MS; Safizadeh H
    Arch Iran Med; 2013 Feb; 16(2):93-9. PubMed ID: 23360631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of disease progression in ductal carcinoma in situ of the breast and vascular patterns.
    Adler EH; Sunkara JL; Patchefsky AS; Koss LG; Oktay MH
    Hum Pathol; 2012 Apr; 43(4):550-6. PubMed ID: 21925705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of progression of ductal carcinoma in situ of the breast to invasive cancer. A hypothesis.
    Cocker R; Oktay MH; Sunkara JL; Koss LG
    Med Hypotheses; 2007; 69(1):57-63. PubMed ID: 17257776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the biologic behavior of ductal carcinoma in situ: an analysis of molecular markers.
    Hieken TJ; Farolan M; D'Alessandro S; Velasco JM
    Surgery; 2001 Oct; 130(4):593-600; discussion 600-1. PubMed ID: 11602889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neovascularization in mucinous ductal carcinoma in situ suggests an alternative pathway for invasion.
    Gadre SA; Perkins GH; Sahin AA; Sneige N; Deavers MT; Middleton LP
    Histopathology; 2008 Nov; 53(5):545-53. PubMed ID: 18983463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microvessel quantitation in intraductal and early invasive breast carcinomas.
    Santinelli A; Baccarini M; Colanzi P; Fabris G
    Anal Quant Cytol Histol; 2000 Aug; 22(4):277-84. PubMed ID: 10965402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.